AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding AC Immune SA changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 64 | 44 | −20 |
| Shares | 17.7M | 15.0M | −2.61M (−14.8%) |
| Value | $118.5M | $74.5M | −$44.0M (−37.1%) |
New holders (5)
Institutions that held AC Immune SA at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 147,435 | $730.0K | 0.00% |
| Susquehanna International Group, LLP | 82,507 | $408.0K | 0.00% |
| Gsa Capital Partners LLP | 73,046 | $362.0K | 0.05% |
| Metatron Capital SICAV plc | 44,000 | $217.8K | 0.21% |
| Strengthening Families & Communities, LLC | 200 | $1.00K | 0.00% |
Sold out (25)
Institutions that held AC Immune SA at the end of Q3 2021 and filed for Q4 2021 without it.